SCHEMBL4854534

SCHEMBL4854534

CN(C)CCOc1ccc(-c2cccnc2)cc1C(=O)/C=C/c1ccccc1CN(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 3/20 0.41
MKNK2 Q9HBH9 3/20 0.41
SLC6A9 P48067 1/20 0.39
KDR P35968 1/20 0.38
CYP1A1 P04798 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP1B1 Q16678 2/20 0.38
HRH1 P35367 1/20 0.38
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
ABCB1 P08183 1/20 0.37
ABCC1 P33527 1/20 0.37
P2RX7 Q99572 1/20 0.36
SYK P43405 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4847761 1.00 MKNK1 (0.41) MKNK1MKNK2SLC6A9KDRCYP1A1
SCHEMBL4847768 0.90 MKNK1 (0.41) MKNK1MKNK2SLC6A9KDRCYP1A1
SCHEMBL4850155 0.86 SLC6A9 (0.45) SLC6A9HRH1SYKKDM4EALDH1A1
SCHEMBL4852871 0.86 SLC6A9 (0.45) SLC6A9HRH1SYKKDM4EALDH1A1
SCHEMBL4856320 0.86 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1ESR1
SCHEMBL4854564 0.86 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1ESR1
SCHEMBL4855113 0.86 HRH1 (0.39) SLC6A9HRH1P2RX7SYKKDM4E
SCHEMBL4849659 0.86 HRH1 (0.39) SLC6A9HRH1P2RX7SYKKDM4E
SCHEMBL4853060 0.85 SYK (0.42) SLC6A9HRH1SYKKDM4EALDH1A1
SCHEMBL4852981 0.85 SYK (0.42) SLC6A9HRH1SYKKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed